Aslakson Eric, Vollmer-Conna Uté, White Peter D
Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Atlanta, GA 30333, USA.
Pharmacogenomics. 2006 Apr;7(3):365-73. doi: 10.2217/14622416.7.3.365.
To validate a latent class structure derived empirically from a clinical data set obtained from persons with chronic medically unexplained fatigue.
The strategies utilized in this validation study included: recalculating latent class analysis (LCA) results varying random seeds and the number of initial random starting sets; recalculating LCA results by substituting alternate variables to demonstrate a robust solution; determining the statistical significance of between-class differences on disability, fatigue and demographic measures omitted from the data set used for LCA; cross-classifying class membership using established Centers for Disease Control and Prevention (CDC) research criteria for chronic fatigue syndrome (CFS) to compare the relative proportions of subjects designated CFS, chronic fatigue (not CFS) or healthy controls captured by the latent classes.
Recalculation of results and substitution of variables for low-loading variables demonstrated a robust LCA result. Highly significant between-class differences were confirmed between Class 2 (well) and those interpreted as ill/fatigued. Analysis of between-class differences for the fatigue groups revealed significant differences for all disability and fatigue variables, but with equivalent levels of reported activity and reduction in motivation. Cross-classification against established CDC criteria demonstrated that 89% of subjects constituting Class 2 (well) were indeed nonfatigued controls. A general tendency for grouping CFS cases in the multiple symptomatic classes was noted.
This study established reasonably good validity for an empirically-derived latent class solution reflecting considerable heterogeneity among subjects with medically unexplained chronic fatigue. This work strengthens the growing understanding of CFS as a heterogeneous entity comprised of several conditions with different underlying pathophysiological mechanisms.
验证从慢性医学无法解释的疲劳患者临床数据集中凭经验得出的潜在类别结构。
本验证研究中采用的策略包括:重新计算潜在类别分析(LCA)结果,改变随机种子和初始随机起始集的数量;通过替代替代变量重新计算LCA结果以证明稳健的解决方案;确定用于LCA的数据集遗漏的残疾、疲劳和人口统计学指标的类别间差异的统计学意义;使用既定的疾病控制和预防中心(CDC)慢性疲劳综合征(CFS)研究标准对类别成员进行交叉分类,以比较潜在类别中被指定为CFS、慢性疲劳(非CFS)或健康对照的受试者的相对比例。
结果的重新计算和低负荷变量的变量替代证明了稳健的LCA结果。第2类(健康)与被解释为患病/疲劳的类别之间证实了高度显著的类别间差异。对疲劳组的类别间差异分析显示,所有残疾和疲劳变量均存在显著差异,但报告的活动水平和动机降低程度相当。根据既定的CDC标准进行交叉分类表明,构成第2类(健康)的受试者中有89%确实是非疲劳对照。注意到将CFS病例分组到多个症状类别的一般趋势。
本研究为凭经验得出的潜在类别解决方案建立了合理良好的有效性,该解决方案反映了医学无法解释的慢性疲劳患者之间的相当大的异质性。这项工作加强了对CFS作为一个由几种具有不同潜在病理生理机制的疾病组成的异质性实体的日益理解。